Gujarat Fluorochemicals Ltd
GFCL credit ratings reaffirmed at CRISIL AA+/Stable; Rs. 3000 Crore bank facilities
RATING
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 27 Mar 2026, 10:31 AM IST · BSE ID: 0936e9f6-d045-42a5-a974-b3aef3f55fb9
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's bank credit ratings stayed strong, confirming lenders view it as financially healthy and reliable to repay loans on time.
🤖 AI Summary
- CRISIL reaffirmed long-term rating CRISIL AA+/Stable on Rs. 3000 Crore bank facilities
- Short-term rating reaffirmed at CRISIL A1+ across all rated bank loan facilities
- Rs. 50 Crore non-convertible debentures rating withdrawn upon maturity redemption
- Nine-month FY26 revenue Rs. 3,628 Crore vs Rs. 3,512 Crore prior year period
- Operating margin recovered to 27% in nine-month FY26 from 23% prior year period
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total Bank Loan Facilities Rated
Rs. 3000 Crore
Long-Term Rating
CRISIL AA+/Stable (Reaffirmed)
Short-Term Rating
CRISIL A1+ (Reaffirmed)
Non-Convertible Debentures Rating
Rs. 50 Crore (Withdrawn)
Nine-Month FY26 Revenue
Rs. 3,628 Crore
3.3
Nine-Month FY26 Operating Margin
27%
Total Debt (Dec 31, 2025)
Rs. 1,532 Crore
Planned Annual Capex
Rs. 1,700 Crore per annum
Battery Chemicals Investment (Jan 2026)
Rs. 1,700 Crore
Expected Interest Coverage
Above 8 times
Expected Net Debt to EBITDA
Below 1.6 times
🏢 How This Affects the Company
Reaffirmed credit ratings strengthen the company's access to debt financing for planned capex of Rs. 1,700 Crore per annum in battery chemicals and new fluoropolymer segments. Strong ratings support ongoing operational expansion in high-growth EV battery and semiconductor markets.
Strong debt protection metrics with debt of Rs. 1,532 Crore as of December 31, 2025, and expected interest coverage above 8 times sustains financial flexibility. Net debt to EBITDA ratio expected below 1.6 times over medium term, supporting credit quality.
Third-quarter operating performance was constrained by US tariff impacts, holiday-season demand weakness, and production quota restrictions in fluorochemicals business affecting R-22 volumes. Recovery dependent on tariff rationalization and destocking completion in fluoropolymers segment.
👥 What This Means For Shareholders
✅
Action Required
No action required. Rating reaffirmation is an informational disclosure under Regulation 30 LODR.
👤
Who Is Affected
All equity and debt holders. Rating reaffirmation maintains confidence in the company's ability to service Rs. 3000 Crore in rated bank facilities and reduces refinancing risk.
🔍
Management Signal
Management's operational recovery trajectory in core fluorochemicals and planned expansion in battery chemicals segment are validated by independent credit agency. Focus remains on execution of capex roadmap.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q4 FY26 results in June 2026 — track fluoropolymers margin recovery post-Q3 tariff impact
H1 FY27 results — monitor new fluoropolymer segment revenue contributions and margin trajectory
Next annual credit rating review — verify debt-to-EBITDA sustains below 1.6 times ratio
MEDIUM RISK
US tariff impacts and production quota restrictions constrained Q3 performance. Battery chemicals ramp-up with Rs. 1,700 Crore invested shows no material revenue yet. Execution risk on capex plan and tariff normalization timing.
💡 Investor Takeaway
CRISIL reaffirmed ratings on Rs. 3000 Crore bank facilities at AA+/Stable, reflecting sustained healthy operations and robust debt metrics. Nine-month FY26 revenue Rs. 3,628 Crore with 27% operating margin, though Q3 faced tariff and quota pressures. Debt at Rs. 1,532 Crore with interest coverage above 8 times expected.
⚖️ Strengths & Concerns
✅ Positives
- Operating margin recovery to 27% in nine-month FY26, up from 23% prior year period
- Robust debt protection with interest coverage expected above 8 times over medium term
⚠️ Concerns
- Third-quarter margin subdued due to US tariffs and production quota restrictions on R-22
- Battery chemicals segment invested Rs. 1,700 Crore as of January 2026 with no significant FY26 revenue contribution